Easing your Screening
The leading manufacturer of ready-to-use cell culture plates
Everyday solutions for your in vitro ADME-Tox needs
Everyday solutions for your in vitro ADME-Tox needs
ReadyCell facilitates and streamlines drug discovery and development study assays with readily available kits that are stored and transported at room temperature.
Pre-Plated Products
Our cell-based ready-to-use kits maximize efficacy and safety testing of active molecules as an alternative to animal testing for drug discovery.
Worldwide Shipping
Thanks to our innovative and patented Shipping Medium, a gel-like preservation matrix, we send cells at room temperature around the globe.
Cost-Saving Assays
Allow your business to respond better to market needs, have a reliable provider of high-quality cell kits, and reduce your capital expenditure.
Do you want to know more about ReadyCell?
Discover our innovative monolayer ADME in vitro assay tools plus efflux and absorption transporters and toxicity metabolism.
ReadyCell is attending the 4th Brain Barriers Summit in Boston
Our ReadyCell sales representative Carla Sapienza will travel next August 29th, 30th and 31st to Boston to attend the Brain Barriers Summit, an event that aims to join industry experts through a discursive forum and evaluate how neuropharmaceuticals can be targeted.
New hyperoxia drug study references CacoReady Kits
The publication, entitled Daily Intraperitoneal Administration of Rosiglitazone Does Not Improve Lung Function or Alveolarization in Preterm Rabbits Exposed to Hyperoxia, was aimed at testing the efficacy of three types of Thiazolidenoides (TZN) in preterm rabbits with bronchopulmonary dysplasia.
Hepatic drug elimination: The role of OATPs and MRP2 transporters
OATP1B1 and OATP1B3 are two influx transporters of the SLCO gene family that are primarily expressed in the sinusoidal membrane of hepatocytes.
New ICH M12 guideline for the regulation of drug interaction studies
Last month, the ICH launched a draft on Drug Interaction Studies regulatory. The guideline includes the regulations of the European, American and Japanese medical agencies and covers both in vitro and clinical studies.